Traci McCarty | executive |
Jean-Jacques Bienaimé | executive |
Jeffrey Ajer | executive |
Henry Fuchs | executive |
Brian Mueller | executive |
Salveen Richter | analyst |
Geoffrey Meacham | analyst |
Philip Nadeau | analyst |
Robyn Karnauskas | analyst |
Joseph Schwartz | analyst |
Christopher Raymond | analyst |
C. Guyer | executive |
Paul Matteis | analyst |
Hello, and welcome to the BioMarin Pharmaceutical Third Quarter 2023 Conference Call. [Operator Instructions]. I will now turn the conference over to Traci McCarty, Head of Investor Relations. Please go ahead.
Thank you, Jan, and thank you all for joining us today.